<DOC>
	<DOCNO>NCT03013400</DOCNO>
	<brief_summary>This study evaluate effect 'lithium like ' drug call ebselen ( SP-1005 ) versus placebo 'add ' treatment help stabilise hypo/manic symptom bipolar disorder . Half participant receive ebselen half placebo . The trial , last total four week .</brief_summary>
	<brief_title>Ebselen add-on Treatment Hypo/Mania</brief_title>
	<detailed_description>Ebselen , new drug mania Bipolar disorder , formerly know manic depression , condition affect mood , swing one extreme another . Typically , period : - Depression - low mood energy level - Mania hypomania ( less severe ) - high mood overactive energy level A drug call lithium , use stabilise mood , important treatment bipolar disorder number problematic side effect , well tolerated patient require careful monitoring . To replace lithium , safe medicine would clear advantage . The investigator interested antioxidant medicine ( substance may prevent delay cell damage ) call ebselen show work similar way lithium investigator investigate whether might help improve recovery manic episode . The present study aim see whether ebselen , use 'add-on ' treatment help stabilise mood patient experience high mood ( hypo/mania ) . Sixty patient experience hypo/mania give randomised order ( similar toss coin ) either ebselen placebo ( dummy ) addition usual medication three week add-on treatment stop . A final follow visit take place one week study medication stop . Participants outpatient mood monitor questionnaire interview . Activity also monitor use actiwatch ( similar wrist watch ) wear continuously throughout study . A single blood sample optional occur first week treatment check plasma level ebselen inflammatory marker . A positive outcome trial follow long term study ebselen bipolar disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ebselen</mesh_term>
	<criteria>Participant willing able give inform consent participation trial . Male Female , age 1870 year Diagnosed bipolar disorder , screen use Structured Clinical Interview DSM5 ( SCID ) meet Diagnostic Statistical Manual Mental Disorders ( DSM5 ) criteria Manic Hypomanic Episode . Female participant child bear potential male participant whose partner child bear potential must willing ensure partner use effective contraception trial In Investigator 's opinion , able willing comply trial requirement . Willing allow clinical care team ( include General Practitioner ( GP ) ) make aware trial participation . The Clinical team treat patient agreement . Female participant pregnant , lactate plan pregnancy course trial . Known significant renal hepatic impairment . Scheduled elective surgery procedure require general anaesthesia trial . Any significant disease disorder , opinion Investigator , may either put participant risk participation trial , may influence result trial , participant 's ability participate trial . Participants participate another research trial involve investigational product past 12 week . Clinically significant illicit substance alcohol misuse dependence criterion satisfy . Taking lithium . Previous randomisation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>